Phreesia (PHR) Q1 FY27 earnings call: guidance and Q&A

How will the expanded AccessOne facility and ability to serve more provider types impact the cross-selling opportunity and economics for Phreesia's base clients?

Management views the AccessOne expansion as a significant milestone, providing more capital and opening up the addressable market within their noninvestment-grade client base. While it's early to detail economic differences, the focus is on driving cash flow improvement for healthcare providers and leveraging existing trust with clients.

“this was definitely an important milestone to get to. And we think there's other sources of capital as we continue to penetrate this part of the market.”

asked by Sean Dodge · answered by Balaji Gandhi

Given the shift in growth engine from subscriptions to payments and network, what changes are being made to sales and marketing teams and the go-to-market strategy?

Phreesia remains a product-led growth organization. The shift is in monetization, deliberately moderating subscription pricing to drive downstream economics in Payments and Network Solutions. The go-to-market strategy is still product-oriented, focusing on getting new capabilities into providers' hands to drive value, with monetization shifting.

“This is deliberately moderating subscription pricing to keep retention strong, drive the downstream economics in Payments and Network Solutions.”

asked by Stanislav Berenshteyn · answered by Balaji Gandhi

Can you elaborate on the strength seen with the newly launched ProviderConnect product within Network Solutions, and its contribution to guidance versus future growth?

ProviderConnect, launched earlier this fiscal year, is generating excitement and momentum with many wins. It contributes to FY27 guidance but is primarily seen as a runway for fiscal years '28, '29, and '30, diversifying revenue beyond Patient Connect. The team did an excellent job launching it.

“But really, I think the way to think about it is it gives us a runway for fiscal '28, '29, '30, where we're not just relying on the Patient Connect side of things, but on the ProviderConnect side of things.”

asked by Scott Schoenhaus · answered by Balaji Gandhi

Were there Q1 labor cost efficiencies before the restructuring, and what is the future ability to drive margin expansion and further cost efficiency?

Management stated that Q1 margin improvement was due to prior upfront investments in the business and constant efforts to drive efficiency, with nothing out of the ordinary to call out. The May restructuring was a separate, deliberate action. The financial outlook assumes continued margin improvement throughout the year, with confidence in driving growth and good margins.

“we put a lot of capital to work into the business 3, 4 or 5 years ago. And I think we've had a lot of these calls talking about operating leverage. And so we're constantly looking at areas to drive efficiency, but we also made that upfront investment that we thought we'd get years of productivity from.”

asked by Brian Tanquilut · answered by Balaji Gandhi

How are conversations evolving regarding potential incremental budget unlocking for Patient Connect in H2, and what opportunities exist for ProviderConnect to be included in late-year innovation spend?

Management reiterated that the H2 outlook for Network Solutions remains unchanged since the March guidance, with no new updates. For new products like ProviderConnect, the focus is on addressing real needs and friction points for providers, leveraging client feedback, and monetizing these solutions through various avenues.

“I don't think we have really anything worth sharing here, which is obviously why we maintain the revenue guidance for the year.”

asked by Ryan MacDonald · answered by Balaji Gandhi

Why was there a 6% sequential decline in the subscription business, and does management still expect low single-digit growth for this segment for the full year?

Management stated that the sequential decline in the subscription business is part of their strategy to moderate subscription pricing, which is embedded in their overall FY27 outlook. They are not optimizing for this specific revenue line and have different paths to achieve their total revenue guidance of $510 million to $520 million.

“What we can tell you is that the strategy is embedded in the numbers. We feel good about where total revenue per AHSC is headed for the year. And as far as your comment about like sort of where we sort of started in the first quarter, it's very much part of the way we sort of see the year playing out.”

asked by Jailendra Singh · answered by Balaji Gandhi

Can you discuss AHSC growth on a gross versus net basis, and how AccessOne might help stem potential churn going forward?

The reported AHSC growth of 50 net clients in Q1 FY27 is encouraging, indicating more additions than losses. Management believes AccessOne's value proposition, especially its expanded reach into their base clients, can absolutely strengthen client relationships and improve retention.

“we think the value proposition with AccessOne and now being able to even extend that reach into our base clients can absolutely be something that can strengthen the relationships we have with them and strengthen retention.”

asked by Richard Close · answered by Balaji Gandhi

How would you rate the AccessOne transaction against expectations, and can you quantify the expected savings from the restructuring plan?

Management is pleased with the AccessOne transaction, highlighting the expansion of the PNC securitization facility as a key milestone. They noted AccessOne operates with funded (40%) and unfunded (60%) portfolios. The savings from the restructuring plan are baked into the FY27 outlook but were not quantified separately.

“It's baked -- the savings generated are baked into our outlook for the year. We're not going to break out a specific contribution from that, but it's something we'd planned for.”

asked by Gene Mannheimer · answered by Balaji Gandhi